124 related articles for article (PubMed ID: 38334009)
21. Sleep Quality Improvement Enhances Neuropsychological Recovery and Reduces Blood Aβ
Huang H; Li M; Zhang M; Qiu J; Cheng H; Mou X; Chen Q; Li T; Peng J; Li B
Medicina (Kaunas); 2021 Dec; 57(12):. PubMed ID: 34946311
[No Abstract] [Full Text] [Related]
22. Normative Data of Mini-Mental State Examination, Montreal Cognitive Assessment, and Alzheimer's Disease Assessment Scale-Cognitive Subscale of Community-Dwelling Older Adults in Taiwan.
Wei YC; Chen CK; Lin C; Chen PY; Hsu PC; Lin CP; Shyu YC; Huang WY
Dement Geriatr Cogn Disord; 2022; 51(4):365-376. PubMed ID: 35820405
[TBL] [Abstract][Full Text] [Related]
23. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
[TBL] [Abstract][Full Text] [Related]
24. Association of plasma endothelial lipase levels on cognitive impairment.
Yun SM; Park JY; Seo SW; Song J
BMC Psychiatry; 2019 Jun; 19(1):187. PubMed ID: 31216999
[TBL] [Abstract][Full Text] [Related]
25. Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life study.
Götze K; Vrillon A; Bouaziz-Amar E; Mouton-Liger F; Hugon J; Martinet M; Dumurgier J; Cognat E; Zetterberg H; Blennow K; Hourrègue C; Paquet C; Lilamand M
Neurobiol Dis; 2023 Jan; 176():105937. PubMed ID: 36462720
[TBL] [Abstract][Full Text] [Related]
26. Neurofilament Light Chain as a Potential Biomarker in Plasma for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and a Meta-Analysis.
Fan Z; Liu X; Liu J; Chen C; Zhou M
J Integr Neurosci; 2023 Jun; 22(4):85. PubMed ID: 37519166
[TBL] [Abstract][Full Text] [Related]
27. Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer's disease.
Xiao Z; Wu X; Wu W; Yi J; Liang X; Ding S; Zheng L; Luo J; Gu H; Zhao Q; Xu H; Ding D
Alzheimers Res Ther; 2021 Jul; 13(1):123. PubMed ID: 34225797
[TBL] [Abstract][Full Text] [Related]
28. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
29. Cluster analysis dissecting cognitive deficits in older adults with major depressive disorder and the association with neurofilament light chain.
Chen CY; Chiu CC; Huang CY; Cheng YC; Huang MC; Kuo PH; Chen WY
BMC Geriatr; 2024 Apr; 24(1):344. PubMed ID: 38627748
[TBL] [Abstract][Full Text] [Related]
30. Association of Adipokines with Alzheimer's Disease in a Chinese Cohort.
Liu CC; Wang QH; Xin JY; Liu YH; Zeng F; Chen DW; Li HY; Yi X; Zeng GH; Wang YJ; Xiang Y; Chen Y
J Alzheimers Dis; 2023; 96(2):523-533. PubMed ID: 37807776
[TBL] [Abstract][Full Text] [Related]
31. Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
Darmanthé N; Tabatabaei-Jafari H; Cherbuin N;
J Alzheimers Dis; 2021; 82(3):951-964. PubMed ID: 34120902
[TBL] [Abstract][Full Text] [Related]
32. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
33. Influence of plasma matrix metalloproteinase levels on longitudinal changes in Alzheimer's disease (AD) biomarkers and cognitive function in patients with mild cognitive impairment due to AD registered in the Alzheimer's Disease Neuroimaging Initiative database.
Abe K; Chiba Y; Hattori S; Yoshimi A; Asami T; Katsuse O; Suda A; Hishimoto A;
J Neurol Sci; 2020 Sep; 416():116989. PubMed ID: 32603972
[TBL] [Abstract][Full Text] [Related]
34. Performance of Plasma Amyloid β, Total Tau, and Neurofilament Light Chain in the Identification of Probable Alzheimer's Disease in South China.
Jiao B; Liu H; Guo L; Liao X; Zhou Y; Weng L; Xiao X; Zhou L; Wang X; Jiang Y; Yang Q; Zhu Y; Zhou L; Zhang W; Wang J; Yan X; Tang B; Shen L
Front Aging Neurosci; 2021; 13():749649. PubMed ID: 34776933
[No Abstract] [Full Text] [Related]
35. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults.
Trzepacz PT; Hochstetler H; Wang S; Walker B; Saykin AJ;
BMC Geriatr; 2015 Sep; 15():107. PubMed ID: 26346644
[TBL] [Abstract][Full Text] [Related]
36. Informant characteristics are associated with the Clinical Dementia Rating Sum of Boxes scores in the Alzheimer's Disease patients participating in the National Alzheimer's Coordinating Center Uniform Data Set.
Vargas-Gonzalez JC; Chadha AS; Castro-Aldrete L; Ferretti MT; Tartaglia C
Res Sq; 2024 Mar; ():. PubMed ID: 38559129
[TBL] [Abstract][Full Text] [Related]
37. Diagnosing Alzheimer's disease: Which dementia screening test to use in elderly Puerto Ricans with mild cognitive impairment and early Alzheimer's disease?
Rodríguez-Santiago MA; Wojna V; Miranda-Valentín E; Arnold S; Sepúlveda-Rivera V
Alzheimers Dement (Amst); 2024; 16(1):e12554. PubMed ID: 38454965
[TBL] [Abstract][Full Text] [Related]
38. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
[TBL] [Abstract][Full Text] [Related]
39. Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study.
Vrillon A; Ashton NJ; Karikari TK; Götze K; Cognat E; Dumurgier J; Lilamand M; Zetterberg H; Blennow K; Paquet C
J Neurol; 2024 Mar; 271(3):1297-1310. PubMed ID: 37950758
[TBL] [Abstract][Full Text] [Related]
40. [Correlation of muscle strength with cognitive function and medial temporal lobe atrophy in patients with mild to moderate Alzheimer's disease].
Liu SW; Li M; Zhu JT; Zhang YC; Wu YH; Liu CF; Hu H
Zhonghua Yi Xue Za Zhi; 2022 Sep; 102(35):2786-2792. PubMed ID: 36124351
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
